ACPA can be present many years before the onset of clinical arthritis in human RA.3, 16 Therefore, the question arises as to whether the development of overt arthritis can be prevented at the preclinical stage in the ACPA-positive population. This evidence concerns the gene PRTN3 and arthritic joint disease.